Literature DB >> 2832312

Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice.

R M Kris1, R A Yetter, R Cogliano, R Ramphal, P A Small.   

Abstract

BALB/c normal and nude mice were infected with a non-lethal mouse-passaged A/PC/1/73 (H3N2) influenza virus in order to assess the role of T cells on the course of disease of the nose, trachea and lung. The tracheal epithelium of both mouse strains was desquamated by 3 days after infection. Although normal regeneration began, nude mice never completed that regeneration whereas normal mice had fully regenerated tracheas by Day 14. This failure to complete the recovery was also evident from the continued virus shedding by the nude mouse. In order to assess the role of serum antibody on recovery from infection, ferret, goat or mouse antibody to H3N2 influenza virus was passively administered to nude mice after infection. It resulted in a transient decrease in virus shedding from the nose, trachea and lung, and complete but temporary regeneration of the tracheal epithelium. However, later in the course of the infection, when serum antibody levels were no longer detectable, the tracheal epithelium of these animals redesquamated and large amounts of virus were again shed from nose, trachea and lungs. We conclude that: (i) desquamation of the ciliated epithelium of the trachea is not T-cell dependent; and (ii) serum antibody can contribute to temporary recovery from infection, but by itself is insufficient for permanent recovery of the nose, trachea or lung.

Entities:  

Mesh:

Year:  1988        PMID: 2832312      PMCID: PMC1454774     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Air-borne influenza virus A infections in immunized animals.

Authors:  C G LOOSLI; D HAMRE; B S BERLIN
Journal:  Trans Assoc Am Physicians       Date:  1953

3.  Effect of antilymphocyte serum on influenza virus infection in mice.

Authors:  F Suzuki; J Oya; N Ishida
Journal:  Proc Soc Exp Biol Med       Date:  1974-05

4.  Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.

Authors:  T Iwasaki; T Nozima
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

5.  Influenza virus infection in nude mice.

Authors:  J L Sullivan; R E Mayner; D W Barry; F A Ennis
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

6.  Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.

Authors:  R M Kris; R Asofsky; C B Evans; P A Small
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

7.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

8.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

9.  Effects of low- and high-passage influenza virus infection in normal and nude mice.

Authors:  P R Wyde; R B Couch; B F Mackler; T R Cate; B M Levy
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

Authors:  J L Schulman; M Khakpour; E D Kilbourne
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

View more
  21 in total

1.  Role of B cells in maintaining helper T-cell memory.

Authors:  D van Essen; P Dullforce; D Gray
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 2.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection.

Authors:  B S Bender; M P Johnson; P A Small
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

5.  Towards a quantitative understanding of the within-host dynamics of influenza A infections.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

6.  Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice.

Authors:  A Bot; A Reichlin; H Isobe; S Bot; J Schulman; W M Yokoyama; C A Bona
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 7.  CD8 T cell responses to influenza virus infection in aged mice.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Ageing Res Rev       Date:  2011-02-15       Impact factor: 10.895

8.  Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae.

Authors:  Sourya Shrestha; Betsy Foxman; Suzanne Dawid; Allison E Aiello; Brian M Davis; Joshua Berus; Pejman Rohani
Journal:  J R Soc Interface       Date:  2013-07-03       Impact factor: 4.118

Review 9.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

10.  Rituximab-treated patients have a poor response to influenza vaccination.

Authors:  Robert A Eisenberg; Abbas F Jawad; Jean Boyer; Kelly Maurer; Kenyetta McDonald; Eline T Luning Prak; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.